FUJIFILM Diosynth Biotechnologies is an industry leading biologics contract manufacturing organisation with locations in Billingham and Wilton, United Kingdom, Research Triangle Park, NC, USA and College Station, TX USA. FUJIFILM Diosynth Biotechnologies has extensive experience in the development and manufacturing of recombinant proteins, vaccines, monoclonal antibodies, among other large molecules expressed in a wide array of microbial mammalian and insect systems. The company offers a comprehensive list of services from cell line and strain development to process development, analytical development, clinical and commercial manufacturing. The Billingham and RTP sites are FDA-approved for the production of commercial products.
19 Mar 2019
Fujifilm To Acquire Large-Scale Biologics Manufacturing Site From Biogen
FUJIFILM today announced that it has entered into an agreement to acquire Biogen (Denmark) Manufacturing ApS, a large-scale biologics manufacturing site located in Hillerød near Copenhagen, Denmark (“Biogen Hillerød”) from Biogen for approximately US$890 million in cash. Upon closure…
£7 million investment approved for new Fujifilm BioCampas
A £7million investment into a major biotechnology facility has today (November 30) been agreed by the Tees Valley Mayor and the Tees Valley Combined Authority Cabinet. The investment, which will aid the development of FUJIFILM Diosynth Biotechnologies’ £14.5million BioCampus project…